We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Editorial Spotlight | Jan 2021

Chromophore IOLs: What Does the Evidence Say?

Exploring the balance of tradeoffs.

Chromophore IOLs that filter high-energy light can be both beneficial and detrimental to ocular and systemic health. With the widespread evolution of artificial lighting to LED sources, our understanding and implementation of chromophore IOLs must also advance. High-energy short-wavelength light describes a wide swath of the visible light spectrum, including violet (380–460 nm) and blue (460–500 nm) light. Traditional descriptions of chromophore IOLs as yellow versus clear and the oversimplified distinctions of blue-light– versus violet-light–filtering are too vague and only minimally helpful.

To understand the full impact of high-energy light-filtering chromophores, we must consider both the shape of the transmission spectrum and the role that specific wavelengths play in ocular and systemic health. In a recently published article, my colleagues and I reviewed the literature on violet- and blue-light–filtering chromophores.1

EVALUATING CHROMOPHORE IOLS

The three primary areas of consideration when evaluating chromophore IOLs may be summarized as follows.

Visual quality and function. Within the visible light spectrum, high-energy short-wavelength light causes greater scatter (contributing to dysphotopsias), induces more chromatic aberration,2 and causes more visual discomfort. Chromophore IOLs can improve night vision symptoms by reducing light scatter.3 However, because blue light plays an important role in scotopic vision,4 chromophores that filter blue light can have a negative effect on vision in low light. Color perception can also be affected.

Phototoxicity. Short-wavelength, high-energy light also contributes to oxidative stress in the macula by producing reactive oxygen species. Most studies of macular phototoxicity simply group violet and blue light together. In a study that evaluated narrow bands of light, however, the greatest amount of reactive oxygen species formation associated with retinal pigment epithelial cell damage was caused by violet light in the range of 415 to 455 nm, with a peak at 420 nm.5 For optimal photoprotection, violet light should therefore be maximally filtered. Blue-light filtering can also be protective but to a lesser degree.

Circadian rhythm. The circadian rhythm is important for cognition, sleep, metabolism, and many other aspects of physiological health. It is entrained by nonvision-related cells in the retina, known as intrinsically photosensitive retinal ganglion cells. When these cells are stimulated by blue light, particularly in the range of 460 to 480 nm, they release melanopsin, which suppresses melatonin, the hormone driving circadian rhythm function.4,6 Studies have shown that the implantation of a clear IOL improves sleep quality and cognition, but reports have been inconsistent regarding the impact of blue-light–filtering chromophore IOLs on the circadian rhythm.

TRADEOFFS

As with many aspects of IOL design, the ideal transmission profile of chromophores involves a balance of tradeoffs in visual quality and function, phototoxicity, and circadian rhythm. No chromophore is ideal under all circumstances. I would argue that the best approach is to block wavelengths that are known to be detrimental and to transmit wavelengths that may be beneficial. Because of an overlap in the benefits and drawbacks of high-energy wavelengths, it is helpful for a chromophore to have a steep cutoff in the transmission spectrum (Figure).

Figure. Transmission spectra of various IOLs, including those with violet-light– and blue-light–filtering chromophores. Note the steep IOL power–independent cutoff of the violet-light filter versus the broad cutoff of the blue-light filter, which moderately reduces the transmission of important blue light while allowing the transmission of high-energy phototoxic violet light, especially in lower-diopter IOLs.

Both violet and blue light cause light scatter and phototoxicity, but blue light is also important for scotopic vision and circadian rhythm entrainment. It would therefore be optimal to filter violet wavelengths below 420 nm and to transmit blue wavelengths above 450 nm. For extra protection against phototoxicity from blue light, sunglasses can be worn during the daytime and removed when indoors and at nighttime, thus limiting a negative impact on scotopic vision, circadian rhythm function, and color perception.

1. Chang D, Pastuck T, Rosen R, et al. Violet and Blue Light: Impact of High-Energy Light on Vision and Health. J Ophthalmic Stud. 3(2): dx.doi.org/10.16966/2639-152X.119.

2. Zhao H, Mainster MA. The effect of chromatic dispersion on pseudophakic optical performance. Br J Ophthalmol. 2007;91:1225-1229.

3. Hammond BR Jr, Renzi LM, Sachak S, Brint SF. Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clin Ophthalmol. 2010;4:1465-1473.

4. Mainster MA. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol. 2006;90(6):784-792.

5. Marie M, Bigot K, Angebault C, et al. Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells. Cell Death Dis. 2018;9(3):287.

6. Brøndsted A, Lundeman J, Kessel L. Short wavelength light filtering by the natural human lens and IOLs—implications for entrainment of circadian rhythm. Acta Ophthalmol. 2013;91:52-57.

author
Daniel H. Chang, MD
  • Cataract and refractive surgeon, Empire Eye and Laser Center, Bakersfield, California
  • Member, CRST Editorial Advisory Board
  • dchang@empireeyeandlaser.com
  • Financial disclosure: Consultant (Johnson & Johnson Vision)

NEXT IN THIS ISSUE